Exhibit 32.2
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection  with the Quarterly  Report of CytoGenix,  Inc. (the "Company") on
Form 1O-Q for the period  ended June 30, 2008 as filed with the  Securities  and
Exchange  Commission  on the date  hereof  (the  "Report"),  I,  Randy  Moseley,
certify,  pursuant to 18 U.S.C.  ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

     (1)The  Report fully  complies  with the  requirements  of section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

     (2)The information contained in the Report fairly presents, in all material
     respects, the financial condition and result of operations of the Company.


September 19, 2008



/s/Randy Moseley
- -----------------
Randy Moseley
Prinicpal Financial Officer